Anti-HLA-B7 Antibody, clone BB7.1, PE Conjugate

Description

• General description: BIOCHEMISTRY: p I = 6.3
• Specificity: Binds to the HLA-B7 antigen. It does not bind to HLA-B27 or other related HLA antigens. Cell type Reactivity Homozygous HLA-B7 ++ Heterozygous HLA-B7 + Heterozygous HLA-B27 - Non-HLA-B7, B27 -
• Immunogen: Papain solubilized HLA-B7 antigen1
• Application: Flow cytometry - Use 10 μL direct from the vial per 100 μL of whole blood, or 1 x 10E6 peripheral blood mononuclear cells (PBMC) in 100 μL buffer. Optimal working concentrations must be determined by the end user.
• Physical form: Protein A purified
• Storage and Stability: Maintain for 1 year at 2–8°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
• Analysis Note: ControlWidely expressed
• Other Notes: Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
• Legal Information: CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.